<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17058862</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Quintana, L F</dc:author>
<dc:author>Torras, A</dc:author>
<dc:author>Poch, E</dc:author>
<dc:author>Santamaría, J</dc:author>
<dc:author>Butjosa, M</dc:author>
<dc:author>Lladó, A</dc:author>
<dc:description xml:lang="en">Baclofen is a centrally acting gamma-ammino butyric acid agonist that is used like muscular relaxant in disorders with spasticity and intractable hiccups. Although encouraging and safe results were provided 5 mg/day in hemodialysis patients, his pharmacokinetic and pharmacodinamic properties are not well known in end stage renal disease. We present here the case of a hemodialysis patient with intractable hiccups who developed baclofen-associated encephalopathy with this recommended dose.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2006 </dc:date>
<dc:title xml:lang="es">Encefalopatía asociada a baclofeno como tratamiento del hipo refractario en un paciente en hemodiálisis.</dc:title>
<dc:title xml:lang="en">[Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].</dc:title>
<dc:publisher>Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
